Dermatology

Case Report

Cutaneous Plasmacytosis: An Unusual Presentation Sharing Features with POEMS Syndrome?

Cerottini J.-P.a · Guillod J.a · Vion B.b · Panizzon R.G.a

Author affiliations

aDepartment of Dermatology (CHUV/DHURDV), Centre Hospitalier Universitaire Vaudois, Lausanne, and bPrivate practice, Renens, Switzerland

Related Articles for ""

Dermatology 2001;202:49–51

Log in to MyKarger to check if you already have access to this content.


Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!


If you would like to redeem your KAB credit, please log in.


Save over 20% compared to the individual article price.

Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00

Select

Subscribe

  • Access to all articles of the subscribed year(s) guaranteed for 5 years
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates


Select
* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of Case Report

Published online: March 01, 2001
Issue release date: 2001

Number of Print Pages: 3
Number of Figures: 4
Number of Tables: 0

ISSN: 1018-8665 (Print)
eISSN: 1421-9832 (Online)

For additional information: https://www.karger.com/DRM

Abstract

Cutaneous plasmacytosis is a recently described skin disorder consisting of brown to red papules and nodules containing polyclonal plasmacytes. In this particular case, leg ulcers developed but also a diffuse patchy hyperpigmentation coexisting with a primary hypothyrodisim. The last two signs have only been described to date in POEMS syndrome, which is linked to monoclonal plasmacytic proliferation, and might suggest an overlap between these two entities.

© 2001 S. Karger AG, Basel




Related Articles:


References

  1. Shimizu S, Tanaka M, Shimizu H, Han-yaku H: Is cutaneous plasmacytosis a distinct clinical entity? J Am Acad Dermatol 1997;36:876–880.
    External Resources
  2. Lopez-Estebaranz JL, Rodriguez-Peralto JL, Ortiz Romero PL, Vanaclocha F, Iglesias Diez L: Cutaneous plasmacytosis: Report of a case in a white man. J Am Acad Dermatol 1994;31:897–900.
    External Resources
  3. Carey WP, Rico MJ, Nierodzik M, Sidhu G: Systemic plasmacytosis with cutaneous manifestations in a white man: Successful therapy with cyclophosphamide/prednisone. J Am Acad Dermatol 1998;38:629–631.
    External Resources
  4. Nitta Y: Case of malignant lymphoma associated with primary systemic plasmacytosis with polyclonal hypergammaglobulinemia. Am J Dermatopathol 1997;19:289–293.
  5. Lee DW, Choi SW, Park JW, Cho BK: Systemic plasmacytosis: A case which improved with melphalan. J Dermatol 1995;22:205–209.
    External Resources
  6. Watanabe S, Ohara K, Kukita A, Mori S: Systemic plasmacytosis: A syndrome of peculiar multiple skin eruptions, generalized lymphadenopathy, and polyclonal hypergammaglobulinemia. Arch Dermatol 1986;122:1314–1320.
  7. Bardwick PA, Zvaifler NJ, Gill GN, Newman D, Greenway GD; Resnick DL: Plasma cell dyscrasia with polyneuropathy, organomegaly, endocrinopathy, M protein and skin changes: The POEMS syndrome. Report on two cases and a review of the literature. Medicine 1980;59:311–322.
  8. Ishikawa O, Nihei Y, Ishikawa H: The skin changes of POEMS syndrome. Br J Dermatol 1987;117:523–526.
    External Resources
  9. Shelley WB, Shelley ED: The skin changes in the Crow-Fukase (POEMS) syndrome: A case report. Arch Dermatol 1987;123:85–87.
    External Resources
  10. Perniciaro C: POEMS syndrome. Semin Dermatol 1995;14:162–165.
  11. Uhara H, Saida T, Ikegawa S, Yamazaki Y, Mikoshiba H, Nijoh S, Kitano K, Koh CS: Primary cutaneous plasmacytosis: Report of three cases and review of the literature. Dermatology 1994;189:251–255.
  12. Halter SA, Dellon AL: Relationship of lymphoplasmacytic infiltration of skin tumors to tumor ulceration. J Surg Oncol 1983;24:15–22.
    External Resources
  13. Dereure O, Guillot B, Dandurand M, Bataille R, Chertok P, Donadio D, Blotman F, Barneon G, Guilhou JJ: Les signes cutanés du syndrome POEMS: à propos de 3 observations et revue de la littérature. Ann Dermatol Vénéréol 1990;117:283–290.
  14. Morrow JS, Schaefer E, Huston DP, Rosen SW: POEMS syndrome: Studies in a patient with an IgG K M protein but no polyneuropathy. Arch Intern Med 1982;142:1231–1234.
  15. Fam AG, Rubenstein JD, Cowan DH: POEMS syndrome: Study of a patient with proteinuria, microangiopathic glomerulopathy and renal enlargement. Arthitis Rheum 1986;29:233–241.

Article / Publication Details

First-Page Preview
Abstract of Case Report

Published online: March 01, 2001
Issue release date: 2001

Number of Print Pages: 3
Number of Figures: 4
Number of Tables: 0

ISSN: 1018-8665 (Print)
eISSN: 1421-9832 (Online)

For additional information: https://www.karger.com/DRM


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
TOP